IKNA Ikena Oncology, Inc.: Company Short-Term Debts
Ikena Oncology, Inc. (IKNA) management is currently optimizing its clinical trial plan, focusing on the most promising developments backed by substantial capital. The company's price evolution, with a metric of 0.00, illustrates the dynamics of a business developing drugs to combat solid tumors, leveraging the success of the IK-930 inhibitor. Stable revenue is secured by long-term patent ownership of innovative molecules for targeted therapy.
IKNA (Ikena Oncology Inc.): analytical breakdowns and indicator data
- stock price and consensus target price:
- company stock capitalization data:
- business book valuation details:
- debt and liquidity details:
Total Debt to Capital Ikena Oncology, Inc.|IKNA - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Ikena|IKNA - Company Aggregate Debts|Debt to Book Capitalization Ratio Ikena Oncology, Inc.|IKNA - Company Long-Term Loans and Borrowings|Company Short-Term Debts Ikena Oncology|Quick Ratio ikenaoncology.com
- earnings and multiples data:
Analysis of all company metrics:IKNA - ikenaoncology.com
Ikena Oncology, Inc. (IKNA) focus on proprietary targeted molecules optimizes R&D expenditures, which directly impacts the liability structure. An analysis of the short-term debt portfolio allows for an assessment of loans maturing within one year, determining current liquidity and the company's ability to service debt without compromising drug development.
Competing companies
BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debts CTOR|Short-Term Debt Volume tuhurabio.com|Company Short-Term Debt Protara Therapeutics, Inc. TARA|Company Short-Term Debts Fate Therapeutics Inc FATE|Aadi Bio - Company Short-Term Debts|Short-Term Debt TScan Therapeutics|championsoncology.com (CSBR) - Company Short-Term Debt|Company Short-Term Indebtedness XBIT|CVM (CEL-SCI Corp.) - Company Short-Term Debts|Company Short-Term Debts OS Therapies Inc.|Company Current Liabilities RADX (Radiopharm Theranostics)|ARTV (artivabio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Adlai Nortye ANL|verupharma.com (VERU) - Short-Term Debt|TPST - Company Short-Term Debt|XLO (Xilio Therapeutics, Inc.) - Company Short-Term Indebtedness|RENB: Company Short-Term Debts|Company Current Liabilities Mural Oncology|Company Short-Term Debt Kairos Pharma Limited|Short-Term Debt OnKure OKUR|Company Short-Term Debt CytoMed Therapeutics (GDTC)|Company Short-Term Debt CRIS (curis.com)|Company Short-Term Debt Apollomics APLM|Tharimmune Corporation (THAR) - Short-Term Debt|Advanced Biomed Corp - Company Short-Term Debts|Short-Term Indebtedness genprex.com (GNPX)|CLDI (calidibio.com) - Company Current Liabilities|Short-Term Debt sunshinebiopharma.com (SBFM)|Company Current Liabilities XBIO|SLRX: Company Short-Term Loans and Borrowings|Company Short-Term Debts PPBT|Short-Term Debt Volume aoncology.com|Company Short-Term Debt BeiGene BGNE|CKPT: Company Short-Term Indebtedness|Elevation Oncology - Company Short-Term Debts|iCAD, Inc. (ICAD) - Company Current Liabilities|NTBL (Notable Labs, Ltd.) - Company Current Liabilities|VIRX - Short-Term Debt Volume|MOR (MorphoSys) - Company Short-Term Debts|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Short-Term Debt Ascentage Pharma Group Ltd (AAPGV)